Literature DB >> 1956087

Retreatment of advanced esthesioneuroblastoma with high-activity I-125 endocurietherapy: a case report.

P P Kumar1, F P Ogren, R D McComb, E O Jones, G F McCaul.   

Abstract

A 67-year-old woman presented with an advanced esthesioneuroblastoma that recurred 2 years following external irradiation. She was successfully retreated with continuous low-dose rate interstitial irradiation from high-activity I-125 seeds implanted permanently into the tumor.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1956087      PMCID： PMC2627124     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  13 in total

1.  Olfactory neuroblastoma. A clinical analysis of 17 cases.

Authors:  S Kadish; M Goodman; C C Wang
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

2.  High-activity iodine-125 endocurietherapy for head and neck tumors.

Authors:  P P Kumar; R R Good; A J Yonkers; F P Ogren
Journal:  Laryngoscope       Date:  1989-02       Impact factor: 3.325

3.  Permanent high-activity iodine-125 in the management of petroclival meningiomas: case reports.

Authors:  P P Kumar; R R Good; A A Patil; L G Leibrock
Journal:  Neurosurgery       Date:  1989-09       Impact factor: 4.654

Review 4.  Esthesioneuroblastoma.

Authors:  D Elkon; S I Hightower; M L Lim; R W Cantrell; W C Constable
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

5.  Olfactory neuroepithelioma. Review of the world literature and presentation of two cases.

Authors:  E M Skolnik; F S Massari; L T Tenta
Journal:  Arch Otolaryngol       Date:  1966-12

6.  Esthesioneuroblastoma: a comparison of two treatment eras.

Authors:  C A Spaulding; M S Kranyak; W C Constable; F M Stewart
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-09       Impact factor: 7.038

Review 7.  High activity iodine 125 endocurietherapy for recurrent skull base tumors.

Authors:  P P Kumar; R R Good; L G Leibrock; J R Mawk; A J Yonkers; F P Ogren
Journal:  Cancer       Date:  1988-04-15       Impact factor: 6.860

8.  Treatment of advanced esthesioneuroblastoma with high-dose chemotherapy and autologous bone marrow transplantation. A case report.

Authors:  G T O'Conor; C R Drake; M E Johns; W S Cail; H R Winn; E Niskanen
Journal:  Cancer       Date:  1985-01-15       Impact factor: 6.860

9.  Immunohistochemical diagnosis of olfactory neuroblastoma.

Authors:  H S Choi; P J Anderson
Journal:  J Neuropathol Exp Neurol       Date:  1985-01       Impact factor: 3.685

10.  Esthesioneuroblastoma masquerading as extramedullary plasmacytoma.

Authors:  R A Abrams; J F Wilson; R A Komorowski; D Collins; R J Toohill
Journal:  Cancer       Date:  1987-07-01       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.